Abstract
Clinical proteomics encompasses a multitude of experimental approaches, tools, and techniques based on proteomics technology which are directly aimed to accelerate and improve diagnosis and treatment of human diseases. Surface-enhanced laser desorption ionization time-of-flight (SELDI-TOF) mass spectrometry is a variant of matrix-enhanced laser desorption ionization (MALDI) that makes use of chemically-modified surfaces to reduce the complexity of biological samples prior to separation in the mass analyzer. Compared to other proteomic techniques, SELDI has several important advantages such as ability to analyze complex biological samples with minimal pre-processing, ease of handling and high throughput. Importantly, once the biomarker or combination of biomarkers with potential clinical value has been established, validation analyses can be conducted in close proximity to clinical settings which is important for establishing the utility of new diagnostics in clinical decision making and perhaps future theranostic interventions. This chapter provides protocols for experimental design and methodology aimed at (1) discovering biologically relevant biomarkers in amniotic fluid using SELDI-TOF; (2) validating the clinical utility of the biomarkers as new diagnostics; (3) translating the biomarker findings into pathophysiological phenomena to provide further insight and extend the current understanding of the disease process. Many of the principles described herein for amniotic fluid could be generalized to studies involving other types of biological samples and other clinical questions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Buhimschi, C.S., Bhandari, V., Hamar, B.D., Bahtiyar, M.O., Zhao, G., Sfakianaki, A.K., Pettker, C.M., Magloire, L., Funai, E., Norwitz, E.R., Paidas, M., Copel, J.A., Weiner, C.P., Lockwood, C.J. and Buhimschi, I.A. (2007). Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 4: e18.
Buhimschi, I.A., Christner, R. and Buhimschi, C.S. (2005). Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG. 112: 173–181.
Buhimschi, I.A., Buhimschi, C.S., Weiner, C.P., Kimura, T., Hamar, B.D., Sfakianaki, A.K., Norwitz, E.R., Funai, E.F. and Ratner, E. (2005). Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form. Clin. Diagn. Lab. Immunol. 12: 837–844.
Buhimschi, I.A., Buhimschi, C.S., Christner, R. and Weiner, C.P. (2005). Proteomics technology for the accurate diagnosis of inflammation in twin pregnancies. BJOG. 112: 250–255.
Buhimschi, C.S., Pettker, C.M., Magloire, L.K., Martin, R., Norwitz, E., Funai, E. and Buhimschi, I.A. (2005). Proteomic technology and delayed interval delivery in multiple pregnancies. Int. J. Gynaecol. Obstet. 90: 48–50.
Weiner, C.P., Lee, K.Y., Christner, R., Buhimschi, I.A. and Buhimschi, C.S. (2005). Proteomic biomarkers that predict the clinical success of rescue cerclage. Am. J. Obstet. Gynecol. 192: 710–718.
Buhimschi, I.A., Zambrano, E., Pettker, C.M., Bahtiyar, M.O., Paidas, M., Rosenberg, V.A., Thung, S., Salafia, C.M. and Buhimschi, C.S. (2008). Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis. Obstet. Gynecol. 111: 403–412.
Buhimschi, C.S., Buhimschi IA, Abdel-Razeq S. Rosenberg, V.A., Thung, S.F., Zhao, G., Wang, E. and Bhandari, V. (2007). Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr. Res. 61: 318–324.
Buhimschi, I.A., Zhao, G., Abdel-Razeq, S., Rosenberg, V.A., Thung, S.F. and Buhimschi, C.S. (2008). Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PLoS ONE. 3: e2049.
Norwitz, E.R., Tsen, L.C., Park, J.S., Fitzpatrick, P.A., Dorfman, D.M., Saade, G.R. Buhimschi, C.S. and Buhimschi, I.A. (2005). Discriminatory proteomic biomarkers analysis identifies free hemoglobin in cerebrospinal fluid of women with severe preeclampsia. Am J Obstet Gynecol. 193: 957–64.
Buhimschi, I.A., Zhao, G., Funai, E.R., Harris, N., Sasson, I., Bernstein, I.M., Saade, G.R. and Buhimschi, C.S. (2008). Specific urinary fragments of SERPINA-1 and ALBUMIN are proteomic biomarkers of preeclampsia. Am. J. Obstet. Gynecol. 199: 551.e1–551.e16.
Buhimschi, I.A. and Buhimschi, C.S. (2008). Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth. Placenta. 29: Suppl A: S95–101.
Hu, J., Coombes, K.R., Morris, J.S. and Baggerly, K.A. (2005). The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct. Genomic. Proteomic. 3: 322–331.
Mandrekar, J.N. and Mandrekar, S.J. (2005). Statistical methods in diagnostic medicine using SAS® software. Proceedings of the 30th SAS Users group International Conference (SUGI). Paper 211–230.
Hanley, J.A. and McNeil, B.J. (1983). A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 148: 839−843.
Obuchowski, N. and McClish, D. (1997). Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat. Med. 16: 1529−1542.
Acknowledgments
The conditions for wide profiling have been largely optimized in collaboration with Dr. Rob Christner, PhD to whom the author is deeply indebted. This work was supported in part from National Institute of Heath (NIH)/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grant RO1 HD47321 (I.A.B.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Buhimschi, I.A. (2012). Using SELDI-TOF Mass Spectrometry on Amniotic Fluid and for Clinical Proteomics and Theranostics in Disorders of Pregnancy. In: Clarke, C., McCarthy, D. (eds) SELDI-TOF Mass Spectrometry. Methods in Molecular Biology, vol 818. Springer, New York, NY. https://doi.org/10.1007/978-1-61779-418-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-61779-418-6_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-61779-417-9
Online ISBN: 978-1-61779-418-6
eBook Packages: Springer Protocols